At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Trial Of The SYNC APP
In Brief
A clinical study evaluating Wearable Sensor, Blue-blocking glasses, and 3 other interventions for Breast Cancer and 4 related conditions. Completed, enrolled 139 participants across 1 site.
Detailed Summary
Fatigue is a major problem for cancer patients, and one that can persist long after treatment ends. Recent work has demonstrated that light therapy may mitigate or reduce fatigue levels in both cancer patients and cancer survivors. This protocol seeks to assess how lighting interventions distributed through a mobile app affect fatigue, sleep, and quality of life across three populations of cancer patients: breast cancer and prostate cancer, and patients who have undergone autologous hematopoietic stem cell transplant (HSCT). Participants will be randomized 1:1 to either the interventional SYNC app or to a control app.
Study Details
Timeline
Interventions
Patient is given a wearable device to wear for 12 weeks.
Patient is given blue-blocking glasses to wear at instructed times.
Patient is given glasses that block no visible light.
Patient downloads the SYNC app and is given light interventions designed to have a targeted, personalized effect on the circadian clock.
Patient downloads the SYNC app and is given light interventions designed to have minimal impact on the circadian clock.